Bioactive Dental Materials: Improving Adhesion, Remineralization, and Longevity of Restorations

Authors

  • Vahideh Lahooti * Faculty of Dentistry, Gilan University of Medical Sciences, Rasht, Iran.

https://doi.org/10.48313/bic.vi.61

Abstract

Bioactive dental materials have emerged as a transformative approach in restorative dentistry, addressing the limitations of conventional materials by combining mechanical function with biological activity. Unlike traditional inert restoratives, these materials actively interact with the oral environment through mechanisms such as ion release, hydroxyapatite formation, pH modulation, and antibacterial effects. This review explores the fundamental properties, classification, mechanisms of action, and clinical applications of bioactive dental materials, with a particular focus on their role in improving adhesion, promoting remineralization, and enhancing the longevity of restorations. Various categories, including bioactive glasses, calcium silicate-based materials, resin-based bioactive composites, ion-releasing systems, and emerging smart materials, are discussed in detail. The ability of these materials to release calcium, phosphate, and fluoride ions plays a critical role in reversing early carious lesions and reinforcing tooth structure. Additionally, their antibacterial properties and improved interfacial bonding contribute to reduced microleakage and lower incidence of secondary caries. Despite these advantages, challenges such as mechanical limitations, long-term stability, esthetic concerns, controlled ion release, and cost remain. Continued advancements in nanotechnology and biomimetic material design are expected to overcome these limitations and further enhance their clinical performance. Overall, bioactive dental materials represent a significant step toward minimally invasive, preventive, and regenerative dental care.

Keywords:

Bioactive dental materials, Remineralization, Ion release, Adhesion, Antibacterial properties, Biodentine

References

  1. [1] U. S. Food and Drug. (2020). Nanotechnology task force. https://www.fda.gov/science-research/nanotechnology-programs-fda/nanotechnology-task-force
  2. [2] European Medicines Agency (EMA). (2024). Concept paper for the development of a guideline on the safety of nanoparticles in the context of veterinary medicinal products and maximum residue limits. https://www.ema.europa.eu/system/files/documents/scientific-guideline/concept-paper-development-guideline-safety-nanoparticle_en.pdf
  3. [3] Martínez, G., Merinero, M., Pérez-Aranda, M., Pérez-Soriano, E. M., Ortiz, T., Villamor, E., … ., & Alcudia, A. (2021). Environmental impact of nanoparticles’ application as an emerging technology: A review. Materials, 14(1), 1-26. https://doi.org/10.3390/ma14010166
  4. [4] Suárez-Oubiña, C., Herbello-Hermelo, P., Mallo, N., Vázquez, M., Cabaleiro, S., Domínguez-González, R., … ., & Bermejo-Barrera, P. (2024). Bioaccumulation and human risk assessment of inorganic nanoparticles in aquaculture species. Environmental science: Nano, 11(7), 2937–2947. https://doi.org/10.1039/D4EN00167B
  5. [5] Niknejad, K., Sharifzadeh Baei, M., & Motallebi Tala Tapeh, S. (2018). Synthesis of Metformin Hydrochloride nanoliposomes: Evaluation of physicochemical characteristics and release kinetics. International journal of nano dimension, 9(3), 298–313. https://ijnd.tonekabon.iau.ir/article_659887.html
  6. [6] Mangla, B., Kumar, P., Javed, S., Pathan, T., Ahsan, W., & Aggarwal, G. (2025). Regulating nanomedicines: challenges, opportunities, and the path forward. Nanomedicine, 20(15), 1911–1927. https://doi.org/10.1080/17435889.2025.2533107
  7. [7] Ho, D., Wang, P., & Kee, T. (2018). Artificial intelligence in nanomedicine. Nanoscale horizons, 4(2). https://doi.org/10.1039/C8NH00233A
  8. [8] Abdul-Rahman, T., Lizano-Jubert, I., Bliss, Z. S. B., Garg, N., Meale, E., Roy, P., … ., & Lavie, C. J. (2024). RNA in cardiovascular disease: A new frontier of personalized medicine. Progress in cardiovascular diseases, 85, 93–102. https://doi.org/10.1016/j.pcad.2024.01.016
  9. [9] Motallebi, S., Mahmoodi, N. O., Ghanbari Pirbati, F., & Azimi, A. (2016). Saccharomyces cerevisiae as a biocatalyst for different carbonyl group under green condition. Organic chemistry research, 2(1), 39–42. https://www.researchgate.net/publication/301694522
  10. [10] Lyons, J.G., Plantz, M.A., Hsu, W.K., Hsu, E.L., & Minardi, S. (2020). Nanostructured biomaterials for bone regeneration. Frontiers in bioengineering and biotechnology, 8. https://doi.org/10.3389/fbioe.2020.00922
  11. [11] Albrektsson, T., & Johansson, C. (2001). Osteoinduction, osteoconduction and osseointegration. European spine journal, 10(2), S96–S101. https://doi.org/10.1007/s005860100282
  12. [12] Gholami, A., Mohkam, M., Soleimanian, S., Sadraeian, M., & Lauto, A. (2024). Bacterial nanotechnology as a paradigm in targeted cancer therapeutic delivery and immunotherapy. Microsystems & nanoengineering, 10(1), 113. https://doi.org/10.1038/s41378-024-00743-z
  13. [13] Naskar, A., Kilari, S., Baranwal, G., Kane, J., & Misra, S. (2024). Nanoparticle-based drug delivery for vascular applications. Bioengineering, 11(12), 1-17. https://doi.org/10.3390/bioengineering11121222
  14. [14] Baniasad, A., Sharifzadeh Baei, M., & Motallebi Tala-Tapeh, S. (2026). Chitosan-PEGylated niosomes and liposomes as biomacromolecule carriers for Alzheimer’s disease treatment: Galantamine drug delivery carrier. Materials chemistry and physics, 352, 132003. https://doi.org/10.1016/j.matchemphys.2025.132003
  15. [15] Rawding, P. A., Bu, J., Wang, J., Kim, D. W., Drelich, A. J., Kim, Y., & Hong, S. (2022). Dendrimers for cancer immunotherapy: Avidity-based drug delivery vehicles for effective anti-tumor immune response. Wiley interdisciplinary reviews. nanomedicine and nanobiotechnology, 14(2), e1752. https://doi.org/10.1002/wnan.1752
  16. [16] Shan, X., Gong, X., Li, J., Wen, J., Li, Y., & Zhang, Z. (2022). Current approaches of nanomedicines in the market and various stage of clinical translation. Acta pharmaceutica sinica b, 12(7), 3028–3048. https://doi.org/10.1016/j.apsb.2022.02.025
  17. [17] Younis, M. A., Tawfeek, H. M., Abdellatif, A. A. H., Abdel-Aleem, J. A., & Harashima, H. (2022). Clinical translation of nanomedicines: Challenges, opportunities, and keys. Advanced drug delivery reviews, 181, 114083. https://doi.org/10.1016/j.addr.2021.114083
  18. [18] Li, M., Zhao, G., Su, W. K., & Shuai, Q. (2020). Enzyme-responsive nanoparticles for anti-tumor drug delivery. Frontiers in chemistry, 8, 647. https://doi.org/10.3389/fchem.2020.00647
  19. [19] Wang, Y., Li, Z., Ouyang, J., & Karniadakis, G. E. (2020). Controlled release of entrapped nanoparticles from thermoresponsive hydrogels with tunable network characteristics. Soft matter, 16(20), 4756–4766. https://doi.org/10.1039/D0SM00207K
  20. [20] Motallebi, S., Baei, M. S., & Keshel, S. H. (2021). Synthesis of thermogel modified with biomaterials as carrier for hUSSCs differentiation into cardiac cells: Physicomechanical and biological assessment. Materials science and engineering: c, 119, 111517. https://doi.org/10.1016/j.msec.2020.111517
  21. [21] Hench, L. L. (2006). The story of Bioglass®. Journal of materials science: materials in medicine, 17(11), 967–978. https://doi.org/10.1007/s10856-006-0432-z
  22. [22] Alfutaimani, A. S., Alharbi, N. K., Alahmari, A. S., Alqabbani, A. A., & Aldayel, A. M. (2024). Exploring the landscape of Lipid Nanoparticles (LNPs): A comprehensive review of LNPs types and biological sources of lipids. International journal of pharmaceutics: x, 8, 100305. https://doi.org/10.1016/j.ijpx.2024.100305
  23. [23] Zhang, P., Xiao, Y., Sun, X., Lin, X., Koo, S., Yaremenko, A. V, … ., & Tao, W. (2023). Cancer nanomedicine toward clinical translation: Obstacles, opportunities, and future prospects. Med, 4(3), 147–167. https://doi.org/10.1016/j.medj.2022.12.001
  24. [24] Xu, H. H. K., Wang, P., Wang, L., Bao, C., Chen, Q., Weir, M. D., … ., & Reynolds, M. A. (2017). Calcium phosphate cements for bone engineering and their biological properties. Bone research, 5(1), 17056. https://doi.org/10.1038/boneres.2017.56
  25. [25] Motallebi, S., Baei, M. S., & Heidar, S. (2020). Evaluation of methylcellulose role in thermosensitive hydrogel structure as injectable system for tissue engineering application: fabrication and characterization. Analytical chemistry, 14(2), 27-46. (In Persian). https://dorl.net/dor/20.1001.1.17359937.1399.14.2.4.4

Downloads

Published

2026-04-10

Issue

Vol. 3 No. 1 (2026): Biocompounds

Section

Articles

How to Cite

Lahooti, V. . (2026). Bioactive Dental Materials: Improving Adhesion, Remineralization, and Longevity of Restorations. Biocompounds, 3(1), 31-44. https://doi.org/10.48313/bic.vi.61

Similar Articles

21-30 of 31

You may also start an advanced similarity search for this article.